An antibody to p16INK4A recognizes a modified form of galectin-3

Hybridoma

Volumn 20, Issue 3, 2001, Pages 167-174

  Gump, J ^a   Koh, J ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY 9E10; ANTIBODY JC 6; GALECTIN 3; MONOCLONAL ANTIBODY; PROTEIN BCL 2; PROTEIN P16; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL TYPE; CONTROLLED STUDY; CYTOLYSIS; EPITOPE MAPPING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY;

ANTIGENS, DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GALECTIN 3; HUMANS; IMMUNODOMINANT EPITOPES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034827755     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/027245701750293493     Document Type: Article

References (40)

1. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
2. CDK inhibitors: Positive and negative regulators of G1-phase progression
3. The p16INK4a/CDKN2A tumor suppressor and its relatives
4. The INK4 family of CDK inhibitors
5. Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1)
6. Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription
7. Preferential activation of the p46 isoform of JNK/SAPK in mouse macrophages by TNF alpha
8. Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains
9. Expression of galectin-3 modulates T-cell growth and apoptosis
10. Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family
11. Identification of galectin-3 as a factor in pre-mRNA splicing
12. Effects of the carbohydrate-bindin g protein galectin-3 on the invasiveness of human breast carcinoma cells
13. The conveyor belt hypothesis for thymocyte migration: Participation of adhesion and deadhesion molecules
14. Human galectin-3 is a novel chemoattractant for monocytes and macrophages
15. Interactions between galectin-3 and Mac-2 binding protein mediate cell-cell adhesion
16. Animal lectins as cell adhesion molecules
17. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties
18. Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death
19. BCL-2 family: Regulators of cell death
20. p16 Inhibition of transformed and primary squamous epithelial cells
21. Functional genomics by mass spectrometry
22. MALDI-TOF mass spectrometry in protein chemistry
23. Mass spectrometry. From genomics to proteomics
24. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages
25. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma
26. Human T lymphotrophic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3
27. Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma
28. Decreased expression of galectin-3 in basal cell carcinoma of the skin
29. Decreased expression of galectin-3 is associated with progression of human breast cancer
30. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells
31. Endoxylanase II from Trichoderma reesei has several isoforms with different isoelectric points
32. Amino acid utilisation and deamination of glutamine and asparagine by Helicobacter pylori
33. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression
34. Increased galectin-3 expression in gastric cancer: Correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation
35. Decreased galectin-3 expression in prostate cancer
36. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation
37. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a
38. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors